Grady Performs First WATCHMAN™ Procedure

Expands Stroke-Prevention Options for AFib Patients

Grady’s Heart & Vascular Center is proud to announce the successful completion of its first WATCHMAN™ Left Atrial Appendage Closure (LAAC) procedure, a major step forward in delivering advanced cardiac care for patients living with non-valvular atrial fibrillation (AFib) who face an increased risk of stroke.

The WATCHMAN device, developed by Boston Scientific, is a minimally invasive implant that helps reduce stroke risk in AFib patients who cannot tolerate long-term blood thinners. The device works by sealing the left atrial appendage, where more than 90% of stroke-causing clots form in AFib patients.

“This milestone reflects our hospital’s commitment to bringing the latest, most advanced cardiac treatments to our community,” said Anekwe Onwuanyi, MD, Chief of Cardiology for Morehouse School of Medicine.

“The WATCHMAN procedure offers a life-changing option for patients who need an alternative to lifelong anticoagulation therapy. We are giving patients safer, more effective options tailored to their unique needs.”

The procedures were performed by Aman Gupta, MD, Ifeoma Ezenekwe, MD, and Caitlin Bradley, MD, a multidisciplinary team that included specialists in structural-interventional cardiology, echocardiography, and anesthesiology. With the addition of the WATCHMAN program, Grady joins a select group of hospitals nationwide offering this innovative stroke-prevention technology.

About Atrial Fibrillation and the WATCHMAN Device

Atrial fibrillation is the most common heart rhythm disorder, affecting more than 5 million Americans. People with AFib are five times more likely to experience a stroke than those with a normal heart rhythm.

The WATCHMAN device has been implanted in more than 300,000 patients worldwide and is supported by strong clinical evidence demonstrating its safety and effectiveness as an alternative to long-term anticoagulant medication.

Congratulations to the entire team for bringing this innovative care option to our patients and community.